Purdue Pharma LP fraudulently transferred funds to members of the wealthy Sackle...
- Purdue Pharma LP fraudulently transferred funds to members of the wealthy Sackler family who control the OxyContin maker despite knowing it faced major liabilities that had made it already insolvent, New York’s attorney general alleged on Thursday.
The lawsuit alleged Purdue and other manufacturers engaged in deceptive marketing that downplayed the dangers of the addictive painkillers and accused distributors of failing to detect the diversion of the drugs for illicit purposes. In a statement, the Sackler family called the lawsuit “a misguided attempt to place blame where it does not belong for a complex public health crisis.”The case is among roughly 2,000 lawsuits filed by state and local governments seeking to hold Purdue and other pharmaceutical companies responsible for the U.S. opioid crisis.
In her lawsuit, James accused Purdue of seeking to “intimidate” states pursuing lawsuits against it by threatening bankruptcy, which would hinder their cases and limit their ability to recover damages.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Purdue Pharma agrees to $270 million settlement in Oklahoma opioid casePurdue Pharma agrees to $270 million settlement in Oklahoma opioid case via ReutersTV
Read more »
OxyContin maker Purdue agrees to settle Oklahoma opioid case: sourcePurdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusin...
Read more »
OxyContin maker Purdue reaches $270 million settlement in Oklahoma opioid case: sourcePurdue Pharma LP and members of the wealthy Sackler family that own the OxyConti...
Read more »
OxyContin maker Purdue Pharma agrees to settle with Oklahoma: sourceNEW: Purdue Pharma has settled with Oklahoma AG for $270M, marking the first significant settlement for a company that faces more than 1,600 cases related to the opioid crisis, according to a person familiar with the matter.
Read more »
OxyContin-maker Purdue Pharma reaches opioid settlement with Oklahoma, sources sayPurdue Pharma agreed to settle the state of Oklahoma’s claims its illegal marketing of the Oxycontin painkiller caused financial devastation to local communities, the first accord in a recent wave of lawsuits stemming from the U.S. opioid crisis, according to people familiar with the matter.
Read more »
OxyContin-maker Purdue Pharma and Sackler family agree to pay $270 million to settle opioid caseThe case against Purdue and other manufacturers was scheduled to go to trial in May. Accusations against the Stamford, Connecticut-based company included downplaying the addiction risk of opioids while overstating the benefits.
Read more »
OxyContin maker Purdue Pharma reaches $270 million settlement related to opioid crisisOxyContin maker Purdue Pharma reaches $270 million settlement related to opioid crisis, with $200 million earmarked for an opioid center at Oklahoma State University.
Read more »
OxyContin-maker Purdue Pharma reaches opioid settlement with Oklahoma Attorney General: SourceOxyContin-maker Purdue Pharma has agreed to settle a lawsuit by the state of Oklahoma accusing it of helping igniting the nationwide opioid crisis, a person familiar with the matter confirmed to CNBC.
Read more »
Sackler Family Actively Trying to Resolve Purdue Pharma LawsuitsMembers of the Sackler family who own OxyContin maker Purdue Pharmahave become more involved in settlement talks to resolve the company’s share of lawsuits accusing drug makers of helping spark the opioid crisis.
Read more »